Synairgen
Phase 2Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for COVID-19.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.4M
About
Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for COVID-19.
Biologics
Funding History
2Total raised:$2.4M
Grant$2.4MJun 15, 2020
IPOUndisclosedOct 15, 2004